Status:
RECRUITING
Azelaic Acid as a Novel Treatment for Central Centrifugal Cicatricial Alopecia (CCCA)
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Central Centrifugal Cicatricial Alopecia
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
The purpose of this pilot study is to determine if azelaic acid shows potential to be an effective treatment for Central Centrifugal Cicatricial Alopecia (CCCA). In this study, the aim is to compare a...
Detailed Description
The management of Central Centrifugal Cicatricial Alopecia (CCCA) is challenging due to limited current treatments and a lack of randomized controlled trials. Management focuses on behavioral and styl...
Eligibility Criteria
Inclusion
- women eighteen years of age or older
- biopsy-proven and /or clinical diagnosis of CCCA Stage II-IV
- on stable treatment without changes for at least three months
- recruited from outpatient dermatology clinics at the Wake Forest Baptist Health Department of Dermatology
Exclusion
- males
Key Trial Info
Start Date :
August 12 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05416333
Start Date
August 12 2024
End Date
December 1 2026
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest University Health Scieces
Winston-Salem, North Carolina, United States, 27157